Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1007/S11033-022-07252-0 | ||||
| Año | 2022 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background Several studies have demonstrated the contribution of innate immune cells, including macrophages, in promoting systemic lupus erythematosus (SLE). Macrophages, one of the most abundant cell populations in the peritoneal cavity, are considered multifunctional cells with phenotypic plasticity. However, the functional properties of peritoneal macrophages in steady-state and during the progression of SLE remain poorly defined. Methods and results Using the [NZB x NZW]F1 (BWF1) murine model of SLE, we analyzed the phenotype and function of peritoneal macrophages during the disease's onset. We found a higher frequency of peritoneal macrophages and B1a cells in BWF1-diseased mice than age-matched controls. Additionally, macrophages from diseased animals expressed lower levels of CD206, MHC-II, and Sirp alpha. RNAseq analysis identified 286 differentially expressed genes in peritoneal macrophages from diseased-BWF1 mice compared to control mice. Functional experiments demonstrate that peritoneal macrophages from diseased-BWF1 mice secrete higher levels of pro-inflammatory cytokines when activated with TLR7 and TLR9 agonists, and they were less efficient in suppressing the activation and proliferation of peritoneal LPS-activated B cells. These data demonstrate that peritoneal macrophages from BWF1-diseased mice present phenotypic and functional alterations shifting to a more pro-inflammatory state. Conclusions The increase of macrophages with an altered phenotype and function together with the accumulation of B1a cells in the peritoneal cavity of diseased-BWF1 mice may promote the progression of the disease. Advancing awareness of the role and phenotype of peritoneal macrophages in SLE may contribute to a better understanding of these types of diseases and the development of novel therapies.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | TEJON, GABRIELA PAOLA | Mujer |
Universidad de Chile - Chile
Universidad San Sebastián - Chile |
| 2 | Valdivieso, Nicolas | Hombre |
Universidad de Chile - Chile
|
| 3 | Flores-Santibanez, Felipe | Hombre |
Universidad de Chile - Chile
|
| 4 | Barra-Valdebenito, Veronica | Mujer |
Universidad de Chile - Chile
|
| 5 | MARTINEZ-RAVANAL, VICTOR MANUEL | Hombre |
Universidad de Chile - Chile
|
| 6 | ROSEMBLATT-SILBER, MARIO CESAR | Hombre |
Universidad de Chile - Chile
Universidad San Sebastián - Chile Ctr Ciencia & Vida - Chile Fundación Ciencia y Vida - Chile Centro Ciencia & Vida - Chile |
| 7 | SAUMA-MAHALUF, DANIELA MACARENA | Mujer |
Universidad de Chile - Chile
|
| 8 | BONO-MERINO, MARIA ROSA | Mujer |
Universidad de Chile - Chile
Ctr Ciencia & Vida - Chile Fundación Ciencia y Vida - Chile Centro Ciencia & Vida - Chile |
| Fuente |
|---|
| FONDECYT |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| FONDEQUIP/EQM |
| Centro Ciencia & Vida |
| Centro Ciencia & Vida, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia ANID |
| Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia ANID |
| Agradecimiento |
|---|
| This work was supported by FONDECYT 3160224 (GT) FONDECYT 1191438 (MRB), 1180385 (DS), FONDEQUIP/EQM 140016 (MRB), Centro Ciencia & Vida, FB210008, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia ANID (MR). |
| This work was supported by FONDECYT 3160224 (GT) FONDECYT 1191438 (MRB), 1180385 (DS), FONDEQUIP/EQM140016 (MRB), Centro Ciencia & Vida, FB210008, Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia ANID (MR). |